Graft invariant natural killer T-cell dose predicts risk of acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation.
Chaidos A, Patterson S, Szydlo R, Chaudhry MS, Dazzi F, Kanfer E, McDonald D, Marin D, Milojkovic D, Pavlu J, Davis J, Rahemtulla A, Rezvani K, Goldman J, Roberts I, Apperley J, Karadimitris A.
Chaidos A, et al. Among authors: roberts i.
Blood. 2012 May 24;119(21):5030-6. doi: 10.1182/blood-2011-11-389304. Epub 2012 Feb 27.
Blood. 2012.
PMID: 22371885
Free PMC article.